Phase I/II Study of Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent Glioblastoma (RGBM)
Phase of Trial: Phase I/II
Latest Information Update: 27 Mar 2019
Price : $35 *
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 15 Mar 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Dec 2019.
- 31 Aug 2018 Biomarkers information updated
- 18 Dec 2017 Status changed from not yet recruiting to recruiting.